Franchini Indrani Lall
- SEC CIK
- 0001708764
No open-market purchases or sales filed in the past year.
Current role at each company
- AVNS Avanos Medical, Inc.Directoras of Jul 28, 2026
- ALNY Alnylam Pharmaceuticals, Inc.EVP, CLO & Secretaryas of Feb 29, 2024
- ALXN Alexion Pharmaceuticals, Inc.EVP, Chief Compliance Officeras of Jul 23, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Franchini Indrani Lall as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALNY Alnylam Pharmaceuticals, Inc.
EVP, CLO & Secretary4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 29, 2024 (view filing) | Feb 28 | 1 day | Franchini Indrani LallEVP, CLO & Secretary | SSale | −329 | $155.30 | −$51.1K | −7.4%4.13K after | 5 lots |
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Franchini Indrani LallEVP, CLO & Secretary | SSale | −1.59K | $170.99 | −$272.1K | −30.7%3.58K after | 3 lots |
| Apr 10, 2023 (view filing) | Apr 6 | 4 days | Franchini Indrani LallEVP, CLO & Secretary | SSale | −3.50K | $210.00 | −$735.0K | −100.0%0 after | |
| Feb 3, 2023 (view filing) | Feb 2 | 1 day | Franchini Indrani LallEVP, CLO & Secretary | SSale | −1.68K | $226.01 | −$378.6K | −32.4%3.50K after | 4 lots |